Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

Osteopontin lactoferrin coacervate complexes: NestleRecent Research Landscape

Bioactive protein bioavailability is limited by degradation during digestion, which is mitigated through the engineering of specific lactoferrin and osteopontin complex structures. These controlled molecular assemblies ensure targeted delivery of high-value nutritional components.

What technical problems is Nestle addressing in Osteopontin lactoferrin coacervate complexes?

Inadequate bioactive protein bioavailability

(8)evidences

Standard infant formulas suffer from poor absorption and bioactivity of essential milk proteins. Enhancing the delivery and stability of these fractions improves developmental outcomes.

Inadequate iron bioavailability

(3)evidences

Iron (II) sulphate monohydrate is prone to poor absorption and gastrointestinal irritation when combined with fatty acids. Improving bioavailability ensures effective nutrient delivery without degradation.